Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807

NCT01733355 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT01733355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01733355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2012
Completion date
March 31, 2013
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ad, alzheimers disease